MedPath
TGA Approval

Hospira Mitoxantrone (concentrate) 30 mg/15 mL injection vial USP (142587)

142587

Hospira Mitoxantrone (concentrate) 30 mg/15 mL injection vial USP

Hospira Australia Pty Ltd

July 27, 2007

Medicine

Medicine

Active

Listed - Exempt

Active Ingredients

mitoxantrone (mitozantrone) hydrochloride

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Hospira Mitoxantrone (concentrate) 30 mg/15 mL injection vial USP (142587) - TGA 批准文号 | MedPath